Effect of Gentian Violet on the treatment of vaginal candidiasis

Effect of Gentian Violet on the treatment of vaginal candidiasis with oral fluconazole: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180917003

Enrollment

200

Registered

2018-09-17

Start date

2018-11-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Single dose of oral 200mg Fluconazole,Single dose of oral 200mg Fluconazole plus vaginal 1cc of Gentain violet

Active Comparator Drug,Active Comparator Drug

Fluconazole,Gentian violet

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: -Non-pregnant women aged at least 18 years -vaginal candidiasis being diagnosed by wet preparation

Exclusion criteria

Exclusion criteria: -Being treated with any antifungal drugs in the previous two weeks -Immunocompromised host such as diabetes mellitus, HIV infection

Design outcomes

Primary

Measure	Time frame
Negative culture for fungus 2 weeks Culture	—

Secondary

Measure	Time frame
Satisfaction 2 weeks rating scale	—

Countries

Thailand

Contacts

Public ContactChenchit Chayachinda

Faculty of Medicine Siriraj Hospital

chenchit.cha@mahidol.ac.th0863123623

Outcome results